| Feature | Influenza (Flu) | COVID-19 (SARS-CoV-2) |
| Virus family | Orthomyxoviridae | Coronaviridae |
| Genome | Segmented (−)ssRNA (8 segments) | Non-segmented (+)ssRNA (~30 kb) |
| Transmission | Droplet, aerosol, fomite | Droplet, aerosol (dominant), fomite |
| Incubation | 1–4 days (avg 2) | 2–14 days (avg 5, shorter for variants) |
| Key symptoms | Fever, cough, myalgia, fatigue, headache | Fever, cough, dyspnea, anosmia/ageusia, fatigue |
| Complications | Pneumonia, myocarditis, encephalitis, Reye's (kids + aspirin) | ARDS, thrombosis, long COVID, MIS-C/MIS-A |
| Vaccines | Annual quadrivalent (IIV, LAIV, RIV) | mRNA, protein subunit, viral vector; updated for variants |
| Antivirals | Oseltamivir, baloxavir, zanamivir | Nirmatrelvir/ritonavir, remdesivir, molnupiravir |